BigHat Biosciences, a protein therapeutics company that combines state-of-the-art AI models with a high-speed automated wet lab, today announced a collaboration with Eli Lilly and Company (Lilly) ...
Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...
Machine learning in drug discovery, along with artificial intelligence, is transforming the pharmaceutical industry by accelerating the development of new treatments. Historically, the process of ...
The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing ...
In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at Stanford University and, until just a few months ago, chief computing ...
The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...
This file handout photo provided to AFP on November 16, 2021 by Pfizer shows the making of its experimental Covid-19 antiviral pills, Paxlovid, at its laboratory in ...
As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...
Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback